Hypotensive Drugs (For Diuretics See 40:28)
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
IRBESARTAN: products 21 to 40 of 41.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Jamp-Irbesartan 150mg TabDIN 02418207 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Irbesartan 300mg TabDIN 02418215 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Jamp-Irbesartan 75mg TabDIN 02418193 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| M-Irbesartan 150mg TabDIN 02524821 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| M-Irbesartan 300mg TabDIN 02524848 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| M-Irbesartan 75mg TabDIN 02524813 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Mint-Irbesartan 150mg TabDIN 02422999 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Mint-Irbesartan 300mg TabDIN 02423006 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Mint-Irbesartan 75mg TabDIN 02422980 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| PMS-Irbesartan 150mg TabDIN 02317079 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| PMS-Irbesartan 300mg TabDIN 02317087 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| PMS-Irbesartan 75mg TabDIN 02317060 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Ran-Irbesartan 150mg TabDIN 02406829 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Ran-Irbesartan 300mg TabDIN 02406837 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Ran-Irbesartan 75mg TabDIN 02406810 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Irbesartan 150mg TabDIN 02328488 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Irbesartan 300mg TabDIN 02328496 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Irbesartan 75mg TabDIN 02328461 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Teva-Irbesartan 150mg TabDIN 02316404 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
| Teva-Irbesartan 300mg TabDIN 02316412 | General benefit | $0.2281per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.